Thursday, June 8, 2023

Fw: Ref.: (LML) Infolep monthly overview of new publications on leprosy. June, 2023

 

Leprosy Mailing List – June 8,  2023

 

Ref.:  (LML) Infolep monthly overview of new publications on leprosy. June, 2023

From:  Roos Geutjes, Josephine Breman-Srivastava, Amsterdam, the Netherlands


 

 




Dear colleagues,

The Bergen International Conference on Hansen's Disease: 150 Years Since the Discovery of the Leprosy Bacillus is happening very soon!  It will take place on June 20-22, 2023, in Bergen, Norway. The conference is organized by Sasakawa Leprosy (Hansen's Disease) Initiative and the University of Bergen in Norway. 

More exciting news! The American Leprosy Mission (ALM), with funding support from Anesvad Foundation and the Raoul Follerau Foundation, launches a ground-breaking Skin Disease Diagnostics Development that can simultaneously detect five skin neglected tropical diseases (Buruli Ulcer, Leprosy, Yaws, Cutaneous Leishmaniasis, and Mycetoma). 

On the 1st of June The Leprosy Mission International and NLR International joined together to host a webinar on post-exposure prophylaxis (PEP) for leprosy. You can watch the recording to hear what experts had to share here. There are more interesting webinars and online side-events happening soon. You can find more information in the News & Events Section of the Newsletter. 

Enjoy reading the latest publications that are listed below. Feel free to contact us to receive the full-text versions when these cannot be found on Infolep. We would also be happy to assist you with literature searches. 


Warm regards,

Roos Geutjes & Josephine Breman-Srivastava

www.leprosy-information.org
info@infolep.org
 

 



 



Highlighted

 



Single-Dose Rifapentine in Household Contacts of Patients with Leprosy.
Wang L, Wang H, Yan L, et al. The New England journal of medicine. 2023; 388 (20) : 1843-1852.
 


Bacterial, fungal and parasitic co-infections in leprosy: A scoping review
Fróes LAR, Toma TS, Jachiet M, et al. PLOS Neglected Tropical Diseases. Public Library of Science (PLoS). 2023; 17 (5) : 1-18.
 


Current Status of Leprosy in the Rural Area of North Gresik, Indonesia After Eliminated Status Achieved: "Is Leprosy Truly Eliminated?"
Kinanti H., Alinda M. D. . Malaysian Journal of Medicine and Health Sciences. 2023; 19 (3) : 272-277.
 


The Global Leprosy Assessment Index (GLAI): A New Approach for measuring the Severity of Disease in Brazil
Silva L, Rocha T, Filho DF. Infectious Medicine. Elsevier BV. 2023.

 



 



New publications


Feel free to contact us to receive full-text versions if these cannot be found through the Infolep portal.

 



Effectiveness and safety of multidrug therapy containing clofazimine for paucibacillary leprosy and clarithromycin for rifampicin-resistant leprosy: a systematic review and meta-analysis.
Montezuma T, Vernal S, Andrade E, et al. Frontiers in medicine. 2023.
 


Temporal trend, high-risk spatial and spatiotemporal clustering of leprosy indicators in Brazil: A 20-year ecological and population-based study.
Paz W, Ramos R, Bezerra L, et al. Tropical medicine & international health : TM & IH. 2023.
 


High seropositivity against NDO-LID in a group of household contacts of leprosy patients. Are we close to leprosy elimination in Colombia?
Serrano-Coll H, Muñoz M, Beltrán J, et al. Pathogens and global health. 2023.
 


Self-reported clinical history of misdiagnosed leprosy cases in the State of Mato Grosso, Brzil, 2016-2019.
Neves K, Machado L, Lisboa M, et al. Cadernos de saude publica. 2023; 39 (5) : e00279421.
 


Evaluation of completeness, consistency and non-duplication of leprosy notification data on the Notifiable Health Conditions Information System, João Pessoa, Paraíba, Brazil: a descriptive study, 2001-2019
Mendes MDS, Oliveira ALSD, Schindler HC. Epidemiologia e Serviços de Saúde. FapUNIFESP (SciELO). 2023.
 


IAL Textbook of Leprosy
Kumar B., Kumar Kar H., Dogra S.. JaypeeDigital. 2023.
 


21 International Leprosy Congress - ILC 2022: A Report on the Conference.
Suneetha S, Rao NP. Indian dermatology online journal. 2023; 14 (3) : 454-456.
 


Epidemiological characteristics of leprosy from 2000 to 2019 in a state with low endemicity in southern Brazil
Moraes PCD, Eidt LM, Koehler A, et al. Anais Brasileiros de Dermatologia. Elsevier BV. 2023.
 


Perfil clínico e epidemiológico dos casos de Hanseníase em Imperatriz-MA entre 2015 e 2021
Oliveira ISV, Ramos EMM, Marques GM, et al. Research, Society and Development. Research, Society and Development. 2023; 12 (5) : 1-11.
 


Análise da qualidade de vida, satisfação e auto-eficácia dos pacientes acometidos com incapacidades pela hanseníase
Rodrigues Uzumaki K. de L.. Pós-Graduação em Reabilitação e Desempenho Funcional (PPGRDF).. Universidade de Pernambuco. 2023.
 


Alterações clínicas da hanseníase associada a Covid-19 em pacientes atendidos em ambulatório de referência: série de casos
dos Santos APL, Costa GV, Ferreira IRP, et al. Brazilian Journal of Health Review. South Florida Publishing LLC. 2023; 6 (3) : 9995-10005.
 


Efecto de la pandemia de covid-19 en el diagnóstico de la lepra en México
Damián-Magaña ÉJ, Sandoval-Navarro K. A., Arenas R., et al. Dermatología Cosmética, Médica y Quirúrgica. 2023; 21 (1) : 13-19.
 


Capacitação para o controle da hanseníase: avaliação e contribuições para a gestão
Cardoso G. C. P. , Santos E. M. dos, Oliviera E. A. de, et al. Saúde Em Debate. 2023; 47 (137) : 90-100.
 


Hanseníase e seus preconceito na atualidade
Marques JDS, Silva NMD, Alves LL. Research, Society and Development. Research, Society and Development. 2023; 12 (5) : 1-8.
 


Análise da Busca Ativa em Exames de Contato de Casos de Hanseníase no Município de Almenara-MG entre 2017-2021
Lopes RS, Nascimento EDS, Coelho VAT, et al. ID on line. Revista de psicologia. Lepidus Tecnologia. 2023; 17 (66) : 240-252.
 


Sistema inteligente para apoio ao diagnóstico de câncer de pele e hanseníase usando análise digital de imagens e redes neurais artificiais profundas
Gomes de Lim P. V. S.. Engenharia Biomédica do Centro de Tecnologia e Geociências. Universidade Federal de Pernambuco. 2023.
 


Comparação do perfil sociodemográfico e clínico de indivíduos com dor neuropática de nociceptiva relacionada à hanseníase
Santos A. H. C., Santos A. F., Siqueira T. S., et al. Scientia Plena. Associação Sergipana de Ciência. 2023; 19 (4) : 1-9.
 


Hubungan personal hygiene dengan kejadian penyakit kusta di puskesmas manguharjo dan ngegong
Widiarini R., Sakufa A., novita l.. Jurnal Ilmu Kesehatan. 2023; 11 (2) : 6-13.
 


Casos de lepra diagnosticados en la unidad de biología molecular del sanatorio fontilles
Soto LA. Revista de Leprología. 2022; 33 (4) : 277-286.
 

 


The development, implementation, and evaluation of an optimal model for the case detection, referral, and case management of Neglected Tropical Diseases
Godwin-Akpan TG, Chowdhury S, Rogers EJ, et al. PLOS ONE. Public Library of Science (PLoS). 2023; 18 (5) : 1-21.
 


Importance of consultations using mobile teams in the screening and treatment of neglected tropical skin diseases in Benin.
Gnimavo R, Fajloun F, Al-Bayssari C, et al. PLoS neglected tropical diseases. 2023; 17 (5) : 1-19.
 


Investigating the sustainability of self-help programmes in the context of leprosy and the work of leprosy missions in Nigeria, Nepal and India: a qualitative study protocol.
Choudhury S, Ilozumba O, Darlong J, et al. BMJ open. 2023.
 


High-resolution ultrasonography for early diagnosis of neural impairment in seropositive leprosy household contacts.
Luppi A, Ferreira G, Prudêncio D, et al. PloS one. 2023; 18 (5) : 1-16.
 


Differential expression of programmed death 1 (PD-1) on various immune cells and its role in human leprosy.
Tarique M, Naz H, Suhail M, et al. Frontiers in immunology. 2023.
 


Mycobacterium leprae's Infective Capacity Is Associated with Activation of Genes Involved in PGL-I Biosynthesis in a Schwann Cells Infection Model.
Chavarro-Portillo B, Soto C, Guerrero M. International journal of molecular sciences. 2023; 24 (10) : 1-18.
 


Association between serum level of vitamin D (25-hydroxyvitamin D) and plasma level of vitamin D receptor with bacteriological index in leprosy patients
Hilma RF, Widaty S, Marissa M, et al. Dermatology Reports. PAGEPress Publications. 2023.
 


Serological IgM antibody profile of M. Leprae PGL-1 and characteristics of leprosy contacts from an endemic area in East Java, Indonesia
Adriyani R, Wahyuni CU, Yudhastuti R, et al. Journal of Public Health in Africa. PAGEPress Publications. 2023.
 


IL-23/IL23R promote macrophage pyroptosis and Th1/Th17 cell differentiation in mycobacterial infection.
Wang C, Liu T, Wang Z, et al. The Journal of investigative dermatology. 2023.
 


DYSREGULATED ILC3S-ILCREGS AXIS IN TYPE 1 REACTIONS (T1R) OF LEPROSY
Saini C, Sapra L, Bhardwaj A, et al. International Journal of Infectious Diseases. Elsevier BV. 2023.
 


Mycobacterial metabolic model development for drug target identification
Bannerman B, Oarga A, Júlvez J. GigaByte (Hong Kong, China). 2023.
 


A New Step in Postexposure Prophylaxis for Leprosy.
Scollard D. The New England journal of medicine. 2023; 388 (20) : 1904-1905.
 


Perfil epidemiológico da hanseníase no município de Lavras da Mangabeira, estado do Ceará, Brasil, nos anos de 2011 a 2020
Firmo JA, Freitas RCD, Queiroga CEGD, et al. Revista Eletrônica Acervo Saúde. Revista Eletronica Acervo Saude. 2023; 23 (5) : 1-10.
 


Perfil epidemiológico dos pacientes com hanseníase em uma Unidade Básica de Saúde Maranhense
Silva JVDA, Oliveira Neto ADD, Silva DS, et al. Revista Eletrônica Acervo Saúde. Revista Eletronica Acervo Saude. 2023; 23 (5) : e11892.
 


Perfil epidemiológico da Hanseníase no Brasil entre 2017 e 2022
Alves APDF, De Oliveira Filho JEL, Gouveia ADDM, et al. Brazilian Journal of Development. South Florida Publishing LLC. 2023; 9 (05) : 15743-15753.
 


Estimativa da prevalência oculta da hanseníase em um município do sul de minas gerais: onde estão os pacientes com hanseníase?
Coelho D. R., Angelo M. C., Dias L. M. R. P., et al. Arquivos de Ciências da Saúde da UNIPAR. 2023; 27 (5) : 3273-3282.
 


Hanseníase na região norte do Brasil: epidemiologia das internações nos últimos dez anos (2013-2022)
Da Costa HD, Tecchio DW, De Souza EB, et al. Brazilian Journal of Health Review. South Florida Publishing LLC. 2023; 6 (3) : 10916-10924.
 


Análise epidemiológica da hanseníase na I Gerência Regional de Saúde de Pernambuco no período de 2017 a 2021
Silva M. Universidade Federal de Pernambuco. 2023.
 


Program fisioterapi dalam pencegahan kecacatan fungsional pada pasien Kusta dengan Xerosis: studi kasus
Andini R. M. , Fatmarizka T., Pristianto A., et al. Journal Physical Therapy UNISA. 2023; 2 (1) : 1-9.
 


Lesiones Neurológicas osteoarticulares en la lepra: una revisión de la fisiopatología y el tratemiento
Frantz J., Echevarría J. R. G.. Revista de Leprología. 2023.

 



 



 



News & Events

 



The Bergen International Conference on Hansen's Disease: 150 Years Since the Discovery of the Leprosy Bacillus
June 20-22, 2023. Bergen, Norway
 

The conference is organized by Sasakawa Leprosy (Hansen's Disease) Initiative and the University of Bergen in Norway. One can expect sessions on the elimination of leprosy; leprosy, stigma, and human rights; social issues and family ties; preserving and communicating the history of leprosy; and ethical and legal aspects. There will also be a cultural side program, and a poster session. 
 


Preparatory Webinar for The Bergen International Conference on Hansen's Disease: on Social Aspects of Leprosy
June 13, 2023;  at 11:00-12:15 (UTC)

This webinar will look at what the 150th anniversary means for medical specialists and persons affected by leprosy from a social perspective. The webinar will feature a presentation from a keynote speaker at the Bergen International Conference, the voices of persons affected by Hansen's disease and a Q&A session with Mr. Yohei Sasakawa, the WHO Goodwill Ambassador for Leprosy Elimination. 
 


COSP #16 to CRPD Side event: Reaching the millions of under-represented people affected by NTDs
June 16th, 2023; at 15:45 CEST

In partnership with Disabled Peoples' International, The Leprosy Mission is hosting a side event at he 16th session of the Conference of States Parties to the CRPD (COSP16) that will consider the people affected by Neglected Tropical Diseases whose voices are under-represented within the disability sector. Guiding discussion points include: why it matters that their voices go unheard, what it is that they could be offering to the sector, and how greater inclusion could be fostered. The panel includes speakers from The Leprosy Mission, Disabled Peoples' International, and CBM International, including persons affected by NTDs.
 


Request Letter for Clinical Images for SEARO Skin NTD Training Toolkit

The WHO South-Eastern Asian Office (SEARO) has shared a request for organizations, researchers, and doctors to share clinical images of Skin-NTDs. SEARO is planning to create a training toolkit that can be utilized by healthcare workers who see patients affected by skin-diseases first-hand. 
 


Frontiers in Pharmacology Call for Articles

The journal Frontiers is calling for articles that highlight potentially novel pharmacological targets and new therapeutics or interventions to treat Neglected Global Diseases. Authors and institutions from  low- or middle-income countries. 
Abstract submission deadline is August 2; and Manuscript submission is December 6.
 

 


Post-Exposure Prophylaxis (PEP) for Leprosy: Explained by some of the world's leading experts
Webinar recording

On Thursday 1 June 2023, The Leprosy Mission International and NLR International joined together to host a webinar on post-exposure prophylaxis (PEP) for leprosy. Leading PEP experts unpacked what PEP means for leprosy, how effective it is in different types of leprosy and over longer periods, how to ensure reliable supplies of rifampicin (the current WHO-endorsed prophylactic), the risk of drug resistance, what PEP will look like in the future, and more.
 


Groundbreaking Skin Disease Diagnostics Development Project launched

American Leprosy Missions (ALM) announced a ground-breaking project in molecular diagnostics to simultaneously detect five skin neglected tropical diseases (NTDs) (Buruli Ulcer, Yaws, Leprosy, Cutaneous Leishmaniasis, and Mycetoma). With funding from the Anesvad Foundation and the Raoul Follereau Foundation, ALM will apply its experience in diagnostic assay development to create a multiplex assay to simultaneously detect the above mentioned skin NTDs. 
 


iChords Podcast: Let's focus on focus groups by The Last Mile

The eighth episode of the "The Last Mile" Podcast discusses how to conduct a successful focus group with Dr. Doris Njomo from the Kenya Medical Research Institute, and Naomi Caplan and Dr. Mekuriaw Alemayehu from the NALA foundation. 
 


NNN Conference 2023
September 19-21, 2023

The NNN Conference 2023 will take place at the Hyatt Regency in Dar Es Salaam, Tanzania. The theme for this years' conference is: "Reaching new frontiers - powering a new generation of leadership and cross-sectoral collaborations to end NTDs." The theme reflects NNN's commitment to cross sectoral collaborations and partnerships centering endemic voices in the fight against NTDS.
 


COR-NTD Annual Meeting
October 16-17, 2023

The COR-NTD Annual Meeting will be held in October in Chicago. The meeting will consists of hybrid plenary sessions, in-person breakout sessions, and a virtual Innovation Lab.
 


COR- NTD Innovation Lab 2023
October 17, 2023

If you have recently been involved with the development of a new strategy, technology or tool with the potential to help NTD programs, you can apply to the Annual COR-NTD Meeting Innovation Lab, to be held virtually on October 17, 2023. This is an opportunity to showcase your innovation for researchers, donors and program implementers attending the meeting. Application Deadline is June 15.

 



 



Links

 



Info Hansen - A innovative hub for knowledge sharing about Hansen's Disease
 


ALLF - Official website of the Association des Léprologues de Langue Française
 


LML - Leprosy Mailing List - a free moderated email list that allows all persons interested in leprosy to share ideas, information, experiences and questions
 


InfoNTD - Information on cross-cutting issues in Neglected Tropical Diseases (NTDs)

 


ILEP newsletter archive


GPZL newsletter subscription


WHO Goodwill Ambassador's Leprosy Bulletin


Leprosy Review


Leprosy Review Repository (1928-2001)


Fontilles Revista de Leprología


Indian Journal of Leprosy


Hansenologia Internationalis


HARP - database of Hansen's Disease Antimicrobial Resistance Profiles

 




GDPR & the Infolep newsletter

 
New EU data protection regulations came into force on 25 May 2018. We have been reviewing our practices with regards to the GDPR, including our privacy statement and mailing list.

Infolep sends out monthly e-mails with an overview of recent publications on leprosy and related issues. The purpose of this activity is to keep subscribers up to date.

Infolep will only process the data we have (names, email addresses) for the purpose of sending you the newsletter. We take your security seriously and will never share your contact details with anyone else.

You can update your preferences or unsubscribe from this list at any time.

 


 



LML - S Deepak, B Naafs, S Noto and P Schreuder

LML blog link: http://leprosymailinglist.blogspot.it/

Contact: Dr Pieter Schreuder << editorlml@gmail.com

--
You received this message because you are subscribed to the Google Groups "Leprosy Mailing List" group.
To unsubscribe from this group and stop receiving emails from it, send an email to leprosymailinglist+unsubscribe@googlegroups.com.
To view this discussion on the web visit https://groups.google.com/d/msgid/leprosymailinglist/784b100e-75be-4c3b-ab79-4f2437d0e46dn%40googlegroups.com.

No comments: